泽泻醇 B T5770
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 18649-93-9 | ¥6,680.00 | 询底价 |
25 mg | 18649-93-9 | ¥4,690.00 | 询底价 |
100 mg | 18649-93-9 | ¥8,850.00 | 询底价 |
1 mL | 18649-93-9 | ¥1,980.00 | 询底价 |
5 mg | 18649-93-9 | ¥1,860.00 | 询底价 |
10 mg | 18649-93-9 | ¥2,820.00 | 询底价 |
1 mg | 18649-93-9 | ¥598.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Alisol B
描述: Alisol B 是一种具有用于骨科疾病研究潜力的化合物,通过分化破骨细胞发挥其功能。
体外活性: Alisol-B, a phyto-steroid from Alisma orientale Juzepczuk, exhibited inhibitory effects on osteoclastogenesis both in vitro and in vivo. Alisol-B did not affect the 1alpha,25(OH)(2)D(3)-induced expressions of RANKL, OPG and M-CSF mRNAs in osteoblasts, addition of alisol-B to co-cultures of mouse bone marrow cells and primary osteoblasts with 10(-8)M 1alpha,25(OH)(2)D(3) caused significant inhibition of osteoclastogenesis. The direct effects of alisol-B on osteoclast precursors. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 95 mg/mL (200.97 mM)
关键字: Alisol B | Inhibitor | inhibit
相关产品: NFATc1-IN-1 | Narlumosbart | Boldine | Denosumab
相关库: Anti-Breast Cancer Compound Library | Bioactive Compounds Library Max | Antidepressant Compound Library | Anti-Ovarian Cancer Compound Library | Traditional Chinese Medicine Monomer Library | Natural Product Library for HTS | Covalent Inhibitor Library | NO PAINS Compound Library | Bioactive Compound Library | Natural Product Library
泽泻醇 B T5770信息由TargetMol中国为您提供,如您想了解更多关于泽泻醇 B T5770报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途